Gardner DenverThird Quarter 2017 Earnings PresentationOctober 26, 2017

Replay Information

▪ Dial toll-free: +1.877.344.7529

▪ International: +1.412.317.0088

▪ Conference ID: #10113255

▪ Log on to: http://investors.gardnerdenver.com

2

Disclaimer

Forward-Looking Statements

During the course of this presentation, we may make “forward-looking statements” within the meaning of the USfederal securities laws. In fact, all statements made during this presentation other than statements of historical factare forward-looking statements. Words such as “expects,” “anticipates,” “believes,” “estimates,” “plans,” “intends,”“projects” and “indicates” and variations of such words or similar expressions are intended to identify forward-looking statements. Although they reflect our current expectations, these statements are not guarantees of futureperformance, and actual results may differ materially from what is expressed in or indicated by these forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actualperformance or results to differ materially from those expressed in such forward-looking statements, including thoserisks and uncertainties described under the section titled “Risk Factors” in our prospectus dated May 11, 2017, filedwith Securities and Exchange Commission (“SEC”) on May 15, 2017, which risks and uncertainties may be updatedfrom time to time in our periodic filings with the SEC (accessible on the SEC’s website at www.sec.gov). Forward-looking statements speak only as of the date the statements are made. The Company does not undertake to updateany forward-looking statements as a result of future developments or new information, except as required by law.

Non-GAAP Financial Measures

Included in this presentation are certain non-GAAP financial measures designed to supplement, and not substitute,the financial information presented in accordance with generally accepted accounting principles in the United Statesof America because management believes such measures are useful to investors. The reconciliation of thosemeasures to the most comparable GAAP measures is detailed in Gardner Denver’s press release for the third quarterof 2017, which is available at http://investors.gardnerdenver.com, together with this presentation.

3

Agenda

▪ Highlights

▪ Financial Performance

▪ Segment Highlights

▪ Full Year 2017 Guidance & Summary

▪ Q&A

4

Q3 Highlights

5

Solid performance across all three segments and continued

execution of our value-creation strategy

A premier industrial company with leading brands, mission-critical technologies, and diverse end market exposure

Strong Execution

Improving Leverage Profile

Favorable Outlook

Revenue of $650M, up 40% versus prior year

Adjusted EBITDA of $165M, up 85% versus the prior year

Adjusted EBITDA margin of 25.4%, an improvement of 620 basis points versus prior year

Free cash flow generation of $54MM, up 210% versus prior year

Net debt to adjusted EBITDA leverage improved from 3.8x to 3.2x versus the

prior quarter & 1.0x turn since the time of the IPO

Increasing 2017 guidance for adjusted EBITDA by 7% to $550M to $560M

Targeting year-end net debt to adjusted EBITDA leverage of ~3.0x

Q3 Highlights – Executing Our Strategy

Deploy Talent

Creating a performance driven culture with highly engaged employees:

– Creating a great place to work – launched multi-year engagement initiative

– Acting like owners – awarded ~$100M in equity across ~6,000 employees

Continue to enhance expertise and talent in critical functions

Expand Margins

Driving Lean Manufacturing across multitude of sites (still early)

Leveraging spend across organization (e.g., freight, sourcing) to generate further savings

Maturing Value Engineering process to drive further product cost reductions

Accelerate Growth

Commercializing new products with new sophisticated Demand Generation process

Embedding smart technologies (e.g., iConn) into products

Leveraging investments in emerging markets - “innovation in the region for the region”

Allocate Capital Effectively

Invest in core: new products, new technologies and emerging markets

Reduce leverage: Net Debt-to-Adjusted LTM EBITDA target

Execute disciplined M&A based on clear strategic and financial criteria

6

Strong Foundation, Clear Strategy, Committed Leadership

Q3 Financial Performance

7¹ Adjusted EPS is defined as adjusted net income divided by adjusted diluted average shares outstanding

(Dollars in millions, excl. EPS)

Revenue

$463

$650

2016 2017

Adjusted EBITDA

$89

$165

2016 2017

Adjusted EPS1

$0.15

$0.41

2016 2017

Up 40% Up 85%Margin Up 620 bps

Up 173%

25.4%Margin

19.2%Margin

Pro-formaIPO

4.2x3.8x

3.2x

Q1'17 Q2'17 Q3'17

Q3 Financial Performance (continued)

8

(Dollars in millions)

LeverageFree Cash Flow1Working Capital(Op. Working Capital as % of LTM Sales) (Net Debt / LTM Adjusted EBITDA)

$18

$54

2016 2017

Improved 110 bps Up 210% Improved 0.6x sequentially

¹ Free Cash Flow is defined as cash flows from operations less capital expenditures

31.9%

30.8%

2016 2017

Q3 Segment Performance

9

Industrials Segment – Q3 Highlights

10

(Dollars in millions)

Highlights:

Orders up 14% as reported; up 11% ex-FX

Revenue up 6% ex-FX

Solid broad-based orders growth with all regions showing

positive momentum versus prior year

Adjusted EBITDA margin up 100 bps benefiting from increased

volume and continued progress on productivity initiatives

(VAVE, lean, restructuring)

Ultima Oil Free Screw CompressorEntering $3B+ oil free market with state-of-the-

art compressor providing > 13% more energy efficiency, > 40% footprint reduction and lower

noise levels than comparable machines.

As Reported

PriorYear

YOYChange

Ex-FX YOY Change

Revenue $288.2 $265.6 8.5% 5.9%

Adjusted EBITDA $63.1 $55.6 13.5% 10.1%

Adjusted EBITDA Margin 21.9% 20.9% 100 bps

Innovation in Action

Energy Segment – Q3 Highlights

11

(Dollars in millions)

Highlights:

Orders up 48% as reported; up 46% ex-FX

Revenue up 116% ex-FX

Upstream revenue up > 250%; mid-downstream up double digits

Aftermarket revenue up 107%; 55% of LTM sales

Adjusted EBITDA margin up 1670 bps benefiting from increased

volume and operational efficiencies

As Reported

PriorYear

YOYChange

Ex-FX YOY Change

Revenue $301.6 $137.9 118.7% 115.9%

Adjusted EBITDA $98.6 $22.0 348.2% 342.7%

Adjusted EBITDA Margin 32.7% 16.0% 1670 bps

Vacuum System for Chemical ManufacturingEngineered system for manufacture of specialty chemicals utilizing both Nash vacuum liquid ring

pumps and Industrial blower technology. First system of its kind manufactured in Gardner Denver’s India

facility.

Innovation in Action

Medical Segment – Q3 Highlights

12

(Dollars in millions)

Highlights:

Orders up 19% as reported; up 17% ex-FX

Revenue up 7% excluding impacts of FX and dual sourcing

customer transition

Seeing an increase in quotations and design specifications for

liquid pumps and liquid handling solutions… solid momentum

heading into 2018.

Adjusted EBITDA margin flat

As Reported

PriorYear

YOYChange

Ex-FX YOY Change

Revenue $59.8 $59.1 1.2% (0.9%)

Adjusted EBITDA $16.8 $16.6 1.2% (1.4%)

Adjusted EBITDA Margin 28.1% 28.1% 0 bps

Gardner Denver MC6000 Syringe PumpEntering genomics end market with multi-

channel syringe pump designed for optimum liquid handling performance and longer life and

reliability.

Innovation in Action

Full Year Guidance and Summary

13

2017 Guidance

▪ Adjusted EBITDA $550M to $560M

▪ Capital Expenditures $50M to $60M

▪ Year End Net Debt Leverage1 ~3.0x

▪ Average Shares Outstanding2 188.2M

142 Represents the full year computation of weighted average shares outstanding and share price as of 9/30/2017

¹ Excluding the impact of any potential future acquisitions

Summary

Across the board strength in Q3

40% revenue growth with double-digit orders growth across all three

segments

25.4% adjusted EBITDA margin with margin expansion of 620 bps

Leverage reduction to 3.2X

4Q 2017 building on current momentum

Raising full year 2017 Adjusted EBITDA guidance

Strong cash flow generation and further reducing leverage position1

Continued execution of our value-creation strategy … Deploy Talent,

Expand Margins, Accelerate Growth and Allocate Capital Effectively

15¹ Excluding the impact of any potential future acquisitions

Q&A

16

Appendix

17

Reconciliation of Net Income/(Loss) and Earnings/(Loss) per Share to Adjusted Net Income and Adjusted Earnings per Share

18

Reconciliation of Net Income/(Loss) to Adjusted EBITDA and Adjusted Net Income and CFOA to Free Cash Flow

19

Reconciliation of Segment Adjusted EBITDA to Income/(Loss) Before Income Taxes

20